| Original language | English (US) |
|---|---|
| Number of pages | 1 |
| Journal | Current Pharmaceutical Design |
| Volume | 24 |
| Issue number | 41 |
| DOIs | |
| State | Published - Jan 1 2018 |
Fingerprint
Drug Therapy
ASJC Scopus subject areas
- Pharmacology
- Drug Discovery
Cite this
Grzybowski, A., Schwartz, S. G., & Kanclerz, P. (2018). Editorial: 2019 update in retinal pharmacotherapies. Current Pharmaceutical Design, 24(41). https://doi.org/10.2174/138161282441190320140728
Editorial : 2019 update in retinal pharmacotherapies. / Grzybowski, Andrzej; Schwartz, Stephen G.; Kanclerz, Piotr.
In: Current Pharmaceutical Design, Vol. 24, No. 41, 01.01.2018.Research output: Contribution to journal › Editorial
Grzybowski, A, Schwartz, SG & Kanclerz, P 2018, 'Editorial: 2019 update in retinal pharmacotherapies', Current Pharmaceutical Design, vol. 24, no. 41. https://doi.org/10.2174/138161282441190320140728
Grzybowski A, Schwartz SG, Kanclerz P. Editorial: 2019 update in retinal pharmacotherapies. Current Pharmaceutical Design. 2018 Jan 1;24(41). https://doi.org/10.2174/138161282441190320140728
@article{3da82a4a0c6848b08cc7f0f54476e759,
title = "Editorial: 2019 update in retinal pharmacotherapies",
author = "Andrzej Grzybowski and Schwartz, {Stephen G.} and Piotr Kanclerz",
year = "2018",
month = "1",
day = "1",
doi = "10.2174/138161282441190320140728",
language = "English (US)",
volume = "24",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "41",
}
TY - JOUR
T1 - Editorial
T2 - 2019 update in retinal pharmacotherapies
AU - Grzybowski, Andrzej
AU - Schwartz, Stephen G.
AU - Kanclerz, Piotr
PY - 2018/1/1
Y1 - 2018/1/1
UR - http://www.scopus.com/inward/record.url?scp=85064263483&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85064263483&partnerID=8YFLogxK
U2 - 10.2174/138161282441190320140728
DO - 10.2174/138161282441190320140728
M3 - Editorial
C2 - 30963967
AN - SCOPUS:85064263483
VL - 24
JO - Current Pharmaceutical Design
JF - Current Pharmaceutical Design
SN - 1381-6128
IS - 41
ER -